Literature DB >> 24917957

Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan.

Hidekazu Suzuki1, Juntaro Matsuzaki1, Sawako Okada1, Kenro Hirata1, Seiichiro Fukuhara1, Toshifumi Hibi1.   

Abstract

BACKGROUND: The GerdQ scoring system may be a useful tool for managing gastro-oesophageal reflux disease. However, GerdQ has not been fully validated in Asian countries.
OBJECTIVE: To validate the Japanese version of GerdQ and to compare this version to the Carlsson-Dent questionnaire (CDQ) in both general and hospital-based populations.
METHODS: The questionnaires, including the Japanese versions of GerdQ and CDQ, and questions designed to collect demographic information, were sent to a general population via the web, and to a hospital-based population via conventional mail. The optimal cutoff GerdQ score and the differences in the characteristics between GerdQ and CDQ were assessed.
RESULTS: The answers from 863 web-responders and 303 conventional-mail responders were analysed. When a GerdQ cutoff score was set at 8, GerdQ significantly predicted the presence of reflux oesophagitis. Although the GerdQ scores were correlated with the CDQ scores, the concordance rates were poor. Multivariate analysis results indicated that, the additional use of over-the-counter medications was associated with GerdQ score ≥ 8, but not with CDQ score ≥ 6.
CONCLUSIONS: The GerdQ cutoff score of 8 was appropriate for the Japanese population. Compared with CDQ, GerdQ was more useful for evaluating treatment efficacy and detecting patients' unmet medical needs.

Entities:  

Keywords:  Cutoff; GERD; GerdQ; questionnaire; unmet medical need

Year:  2013        PMID: 24917957      PMCID: PMC4040759          DOI: 10.1177/2050640613485238

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  21 in total

1.  Serum lipid levels are positively associated with non-erosive reflux disease, but not with functional heartburn.

Authors:  J Matsuzaki; H Suzuki; E Iwasaki; H Yokoyama; Y Sugino; T Hibi
Journal:  Neurogastroenterol Motil       Date:  2010-05-19       Impact factor: 3.598

2.  Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese.

Authors:  Ikuyo Mishima; Kyoichi Adachi; Noriyuki Arima; Kazutoshi Amano; Toshiharu Takashima; Makoto Moritani; Kenji Furuta; Yoshikazu Kinoshita
Journal:  Scand J Gastroenterol       Date:  2005-09       Impact factor: 2.423

3.  Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy.

Authors:  Edoardo Savarino; Radu Tutuian; Patrizia Zentilin; Pietro Dulbecco; Daniel Pohl; Elisa Marabotto; Andrea Parodi; Giorgio Sammito; Lorenzo Gemignani; Giorgia Bodini; Vincenzo Savarino
Journal:  Am J Gastroenterol       Date:  2009-12-08       Impact factor: 10.864

4.  Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.

Authors:  Frank Zerbib; Kafia Belhocine; Mireille Simon; Maylis Capdepont; François Mion; Stanislas Bruley des Varannes; Jean-Paul Galmiche
Journal:  Gut       Date:  2011-10-13       Impact factor: 23.059

Review 5.  Systematic review on epidemiology of gastroesophageal reflux disease in Asia.

Authors:  Benjamin C Y Wong; Yoshikazu Kinoshita
Journal:  Clin Gastroenterol Hepatol       Date:  2006-04       Impact factor: 11.382

6.  Epidemiology of gastroesophageal reflux disease in Asia: a systematic review.

Authors:  Hye-Kyung Jung
Journal:  J Neurogastroenterol Motil       Date:  2011-01-26       Impact factor: 4.924

7.  The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease.

Authors:  R Carlsson; J Dent; E Bolling-Sternevald; F Johnsson; O Junghard; K Lauritsen; S Riley; L Lundell
Journal:  Scand J Gastroenterol       Date:  1998-10       Impact factor: 2.423

8.  Validation of the GerdQ questionnaire for the diagnosis of gastro-oesophageal reflux disease.

Authors:  C Jonasson; B Wernersson; D A L Hoff; J G Hatlebakk
Journal:  Aliment Pharmacol Ther       Date:  2013-01-07       Impact factor: 8.171

9.  Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care.

Authors:  R Jones; O Junghard; J Dent; N Vakil; K Halling; B Wernersson; T Lind
Journal:  Aliment Pharmacol Ther       Date:  2009-09-08       Impact factor: 8.171

10.  Decreased levels of adiponectin in obese patients with gastroesophageal reflux evaluated by videoesophagography: possible relationship between gastroesophageal reflux and metabolic syndrome.

Authors:  Eisuke Iwasaki; Hidekazu Suzuki; Yoshinori Sugino; Tsutomu Iida; Toshihiro Nishizawa; Tatsuhiro Masaoka; Hiroshi Hosoda; Kenji Kangawa; Toshifumi Hibi
Journal:  J Gastroenterol Hepatol       Date:  2008-12       Impact factor: 4.029

View more
  20 in total

1.  A novel prostanoid EP1 receptor antagonist, ONO-8539, reduces acid-induced heartburn symptoms in healthy male volunteers: a randomized clinical trial.

Authors:  Takashi Kondo; Hiroo Sei; Takahisa Yamasaki; Toshihiko Tomita; Yoshio Ohda; Tadayuki Oshima; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2017-01-24       Impact factor: 7.527

2.  Metabolic Dysfunction-Associated Fatty Liver Disease Increases the Risk of Gastroesophageal Reflux Symptoms.

Authors:  Yuan He; Zhi-Jun Duan; Cheng-Fang Wang; Yu-Shan Wei; Ming-Xu Cai
Journal:  Diabetes Metab Syndr Obes       Date:  2022-01-20       Impact factor: 3.168

3.  Vonoprazan 10 mg daily is effective for the treatment of patients with proton pump inhibitor-resistant gastroesophageal reflux disease.

Authors:  Satoshi Shinozaki; Hiroyuki Osawa; Yoshikazu Hayashi; Hirotsugu Sakamoto; Yasutoshi Kobayashi; Alan Kawarai Lefor; Hironori Yamamoto
Journal:  Biomed Rep       Date:  2017-07-20

4.  MicroRNA Expression can be a Promising Strategy for the Detection of Barrett's Esophagus: A Pilot Study.

Authors:  Ajay Bansal; Xiaoman Hong; In-Hee Lee; Kausilia K Krishnadath; Sharad C Mathur; Sumedha Gunewardena; Amit Rastogi; Prateek Sharma; Lane K Christenson
Journal:  Clin Transl Gastroenterol       Date:  2014-12-11       Impact factor: 4.488

5.  Relevance between GerdQ score and the severity of reflux esophagitis in Uygur and Han Chinese.

Authors:  Man Wang; Jing-Zhan Zhang; Xiao-Jing Kang; Li Li; Xiao-Ling Huang; Kuerbanjiang Aihemaijiang; Aheman Ayinuer; Yue-Xian Li; Xiao-Lei He; Feng Gao
Journal:  Oncotarget       Date:  2017-08-10

6.  Gastroesophageal reflux disease in an area with low Helicobacter pylori infection prevalence.

Authors:  Muhammad Miftahussurur; Dalla Doohan; Iswan Abbas Nusi; Pangestu Adi; Yudith Annisa Ayu Rezkitha; Langgeng Agung Waskito; Kartika Afrida Fauzia; Taufan Bramantoro; Ummi Maimunah; Husin Thamrin; Safitri Indah Masithah; Sukadiono Sukadiono; Tomohisa Uchida; Maria Inge Lusida; Yoshio Yamaoka
Journal:  PLoS One       Date:  2018-11-14       Impact factor: 3.240

7.  Influence of regular exercise on gastric emptying in healthy men: a pilot study.

Authors:  Juntaro Matsuzaki; Hidekazu Suzuki; Tatsuhiro Masaoka; Kentaro Tanaka; Hideki Mori; Takanori Kanai
Journal:  J Clin Biochem Nutr       Date:  2016-07-16       Impact factor: 3.114

8.  GASTROESOPHAGEAL REFLUX DISEASE AND ETIOLOGICAL CORRELATES AMONG NIGERIAN ADULTS AT OGBOMOSO.

Authors:  A C Jemilohun; B O Oyelade; J O Fadare; I O Amole
Journal:  Ann Ib Postgrad Med       Date:  2018-06

9.  Burden of impaired sleep quality on work productivity in functional dyspepsia.

Authors:  Juntaro Matsuzaki; Hidekazu Suzuki; Koji Togawa; Tsuyoshi Yamane; Hideki Mori; Takahiro Komori; Tatsuhiro Masaoka; Takanori Kanai
Journal:  United European Gastroenterol J       Date:  2017-08-07       Impact factor: 4.623

10.  The Rome IV versus Rome III criteria for heartburn diagnosis: A comparative study.

Authors:  Mengyu Zhang; Minhu Chen; Sui Peng; Yinglian Xiao
Journal:  United European Gastroenterol J       Date:  2017-09-27       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.